Background illustration for clinical trials search

Paid Clinical Trials Murfreesboro

Discover 1,239 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Multi-Institutional Registry for Prostate Cancer Radiosurgery

for
Prostate Cancer Early Risk Treated by Radiosurgery,
Location: Nashville TN, Birmingham AL, Marietta GA, Lexington KY,
Sponsor: RPCR, Inc.

Sex: Male

Age: 18 - 70+

Code: NCT01226004

Recruiting

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

for
Neoplasms
Location: Nashville TN, Atlanta GA, Greenville SC, Charlotte NC,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06150157

Phase 1, Recruiting

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

for
Myeloproliferative Neoplasms
Location: Nashville TN, Atlanta GA, Columbus OH, Chapel Hill NC,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07441694

Phase 1, Recruiting

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

for
Relapsed Acute Myeloid Leukemia (AML),
Location: Nashville TN, Columbus OH, Chapel Hill NC, Tampa FL,
Sponsor: Auron Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06846606

Phase 1, Recruiting

A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

for
Hematologic Neoplasms
Location: Nashville TN, Indianapolis IN, Grand Rapids MI,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07572006

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

for
T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Location: Nashville TN, Atlanta GA, Cincinnati OH, St Louis MO,
Sponsor: Allotera Therapeutics

Sex: All

Age: 0+

Code: NCT06514794

Phase 2, Recruiting
New

T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd

for
Advanced Breast Cancer, Metastatic Breast Cancer, HER2 Positive,
Location: Nashville TN, Columbia MD, New Braunfels TX, El Paso TX,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07683754

Phase 3, Recruiting

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Prostate Cancer
Location: Nashville TN, Atlanta GA, Cincinnati OH,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT04221542

Phase 1, Recruiting

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

for
Solid Tumor, Adult, Metastatic Breast Cancer,
Location: Nashville TN, Indianapolis IN, St Louis MO,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06625775

Phase 1, Recruiting

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

for
Recurrent or Metastatic Solid Tumors
Location: Nashville TN, Chattanooga TN, Germantown TN, Skokie IL,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06330064

Phase 1, Phase 2, Recruiting

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer,
Location: Nashville TN, Birmingham AL, Peoria IL, Cleveland OH,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06343402

Phase 1, Recruiting

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

for
Breast Cancer
Location: Nashville TN, Salem VA, Columbia MD, Norfolk VA,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT05748834

Phase 2, Recruiting

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

for
Advanced Solid Tumors, HER2 Mutation
Location: Nashville TN, Cleveland OH, Toronto, Houston TX,
Sponsor: Bayer

Sex: All

Age: 18+

Code: NCT06760819

Phase 2, Recruiting

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

for
Ovarian Cancer, Solid Tumor
Location: Nashville TN, Denver CO, Grand Rapids MI, Fairfax VA,
Sponsor: OnCusp Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06234423

Phase 1, Recruiting

LYL273 for Patients With Relapsed or Refractory mCRC

for
Colorectal Cancer
Location: Nashville TN, Boston MA, Aurora CO, Duarte CA,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT05319314

Phase 1, Phase 2, Recruiting

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Nashville TN, Denver CO, Durham NC, Fairfax VA,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06108050

Phase 1, Recruiting

SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

for
Melanoma, Cutaneous Malignant
Location: Nashville TN, Columbus OH, Chapel Hill NC, Chicago IL,
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT06743126

Phase 3, Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: Nashville TN, Atlanta GA, Jonesboro AR, St Louis MO,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase 3, Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

for
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer,
Location: Nashville TN, Birmingham AL, Atlanta GA, Athens GA,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06881784

Phase 3, Recruiting

Study of PF-07248144 in Advanced or Metastatic Solid Tumors

for
Locally Advanced or Metastatic ER+ HER2- Breast Cancer,
Location: Nashville TN, Louisville KY, Edgewood KY, Conroe TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT04606446

Phase 2, Recruiting